This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders Europe
17 - 19 March 2026

Stay ahead in the rapidly evolving world of mRNA therapeutics and vaccines, next-generation RNA, and oligo-based therapeutics.

Gain exclusive access to expert insights, in-depth speaker interviews, and cutting-edge advancements shaping the future of RNA science.

Speaker Interviews

Step into the minds of industry leaders with our exclusive speaker interviews. Gain firsthand insights, inspiring stories, and expert advice that will empower and elevate your journey.

Tamar Grossman: The Future of RNA

Ulrik Lytt Rahbek: Advancing mRNA and RNA Therapies

Next Gen RNA Explainer Series

Step into the minds of industry leaders with our exclusive speaker interviews. Gain firsthand insights, inspiring stories, and expert advice that will empower and elevate your journey.

What's next in RNA Therapies?

Personalised RNA Medicine: A New Frontier

How is AI transforming RNA drug discovery?

Key Insights into RNA Leaders Europe

The mRNA Therapeutics Market: Growth, Challenges, and Opportunities

Beyond mRNA: The Rise of Next-Generation RNA Therapeutics

5 Ways Oligo-Based Therapeutics Are Changing Modern Medicine

300+

mRNA vaccines and therapeutics in development

$21B

Market Size by 2028

211

mRNA drugs in preclinical development

80+

Companies developing RNA-based therapies

300+

Ongoing clinical trials in 2024

20%

Increase in global R&D investment in mRNA technology in 2025

Join Our Community

Stay connected and informed! Follow us on LinkedIn for exclusive insights into event content, daily updates on the latest happenings, and more.

Don’t miss a moment—join the conversation today!